New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer)

.

Saved in:
Bibliographic Details
Main Author: Article Editorial (Author)
Format: Book
Published: Столичная издательская компания, 2016-09-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a2de98d0e48a4bdb99c9a0d5f15e5b0a
042 |a dc 
100 1 0 |a Article Editorial  |e author 
245 0 0 |a New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) 
260 |b Столичная издательская компания,   |c 2016-09-01T00:00:00Z. 
500 |a 1819-6446 
500 |a 2225-3653 
520 |a . 
546 |a EN 
546 |a RU 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Diseases of the circulatory (Cardiovascular) system 
690 |a RC666-701 
655 7 |a article  |2 local 
786 0 |n Рациональная фармакотерапия в кардиологии, Vol 12, Iss 4, Pp 487-488 (2016) 
787 0 |n https://www.rpcardio.online/jour/article/view/1319 
787 0 |n https://doaj.org/toc/1819-6446 
787 0 |n https://doaj.org/toc/2225-3653 
856 4 1 |u https://doaj.org/article/a2de98d0e48a4bdb99c9a0d5f15e5b0a  |z Connect to this object online.